Respiratory Involvement in Children with Inflammatory Bowel Disease

Area of Science:

• Pulmonology
• Gastroenterology
• Internal Medicine

Background:

• Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are systemic conditions with extra-intestinal manifestations.
• Respiratory involvement in IBD, often sub-clinical, may be more prevalent than previously recognized.
• Pulmonary manifestations can occur in both children and adults, with distinct pathological patterns.

Purpose of the Study:

• To highlight the prevalence and characteristics of pulmonary involvement in IBD patients.
• To discuss the diagnostic tools and challenges in identifying lung complications.
• To emphasize the importance of a multidisciplinary approach in managing IBD-associated respiratory issues.

Main Methods:

• Review of existing literature on pulmonary manifestations in IBD.
• Analysis of clinical findings, laboratory tests (e.g., fractional exhaled nitric oxide - FeNO), and imaging techniques (e.g., high-resolution CT).
• Discussion of treatment strategies for pulmonary complications in IBD.

Main Results:

• Elevated FeNO levels are observed in IBD patients, even during remission, indicating airway inflammation.
• Pulmonary lesions vary by age, with granulomatous infiltrates common in children and bronchiectasis/organizing pneumonia in adults.
• Pulmonary function tests (PFTs) show inconsistent abnormalities, except for reduced diffusion capacity for carbon monoxide.

Conclusions:

• Pulmonary involvement in IBD is often asymptomatic and detectable via imaging like CT scans.
• Medications for IBD, such as NSAIDs, can be a risk factor for lung injury.
• Pediatricians and specialists should maintain a high index of suspicion for pulmonary complications in IBD patients.